abstract |
The invention relates to inhibitors of mutant isocitrate dehydrogenase proteins (mt-IDH) with useful neomorphic activity in the treatment of cell proliferation disorders and cancers, having Formula: (I), in which A, U, W1, W2, W3 , R1-R6 and R9 are described herein. |